# FDA recall D-0249-2026

> **Imprimis NJOF, LLC** · Class II · drug recall initiated 2025-12-18.

## Product

Dexamethasone   Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1

## Reason for recall

Presence of particulate matter - Glass like particles.

## Distribution

U.S Nationwide

## Key facts

- **Recall number:** D-0249-2026
- **Recalling firm:** Imprimis NJOF, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-12-18
- **Report date:** 2026-01-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Ledgewood, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0249-2026

## Citation

> AI Analytics. FDA recall D-0249-2026. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0249-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*